Premium
Chemotherapeutic drug effects on spontaneous mobility and swimming endurance of mice
Author(s) -
Pagala Murali K,
Kharode Ishita,
Dahan Nessy,
Arama Leron
Publication year - 2008
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.22.1_supplement.961.3
Subject(s) - doxorubicin , medicine , ambulatory , chemotherapy , drug , anesthesia , pharmacology
Muscle weakness and enhanced fatigue are common complaints of cancer patients undergoing chemotherapy. In order to evaluate the underlying mechanisms, the present study assessed the acute effects of the chemotherapeutic drug, doxorubicin, on spontaneous motor activity and swimming performance of mice. Before and after i.p. injection of doxorubicin at 25 mg/kg into each mouse, the number of spontaneous movements was monitored for 24 hr using Columbus Instruments Opto‐varimax‐mini activity meter, and the integrated swimming activity (V.sec) was recorded for 40 min using a digital swimming monitor (Pagala, 1999). Doxorubicin, within the clinical dose range, significantly reduced the stereotypic, ambulatory, and thus the total number of spontaneous movements of the mice in a 24 hr period (Table 1). Doxorubicin also caused a significant reduction in the integrated swimming activity of the mice over a 40 min period (Table 1). These results indicate that chemotherapeutic agents may significantly decrease the motivation and endurance for physical activity. Supported by a special grant from Maimonides Med. Ctr.